Results 21 to 30 of about 2,675 (153)

MACULAR EDEMA AFTER CATARACT PHACOEMULSIFICATION IN DIABETIC RETINOPATHY AND TYPE 2 DIABETES MELLITUS

Медична наука України
Background. One of the complications of diabetes mellitus is diabetic cataract, which may occur in combination with age-related cataract. Phacoemulsification of cataract with intraocular lens implantation is the gold standard for cataract treatment ...
Olesya Horokhivska
doaj   +1 more source

Role of combined phacoemulsification and intravitreal injection of bevacizumab in prevention of postoperative macular edema in non-proliferative diabetic retinopathy

Journal of Current Ophthalmology, 2018
Purpose: To evaluate the role of combined phacoemulsification and intravitreal injection of bevacizumab in prevention of postoperative diabetic macular edema (DME) in patients with no diabetic retinopathy or non-proliferative diabetic retinopathy (NPDR ...
Alireza Khodabandeh, Shahed Fadaifard, Ali Abdollahi, Reza Karkhaneh, Ramak Roohipoor, Fatemeh Abdi, Hamed Ghasemi, Sam Habibollahi, Mehdi Mazloumi   +8 more
doaj   +1 more source

RANIBIZUMAB MONOTHERAPY VERSUS COMBINED RANIBIZUMAB PLUS TRIAMCINOLONE FOR TREATING DIABETIC MACULAR EDEMA; EVALUATION AFTER SINGLE INJECTION [PDF]

Basrah Journal of Surgery, 2015
Anti vascular endothelial growth factor (Anti-VEGF) have been proved to be the main treatment for DME and also steroids showed a significant role in resolution of diabetic macular edema(DME).
Fareed A AL-Laftah
doaj   +1 more source

Classifications of diabetic macular edema [PDF]

European Journal of Ophthalmology, 2019
Diabetic retinopathy is a major cause worldwide of vision loss from diabetic maculopathy or proliferative retinopathy. Without widely accepted classifications of diabetic retinopathy and diabetic maculopathy, it is difficult to compare results of clinical trials or monitor clinical care.
openaire   +2 more sources

Diabetic macular edema

Saudi Journal of Ophthalmology, 2009
A variety of treatment options are available for the treatment of diabetic macular edema. They include laser photocoagulation, anti-VEGF drugs, intravitreal steroids, and vitrectomy with or without release of vitreoretinal traction. A full understanding of the physiological mechanisms of these treatment modalities allows sensible combination of ...
openaire   +3 more sources

Predicting optical coherence tomography-derived diabetic macular edema grades from fundus photographs using deep learning

Nature Communications, 2020
Diabetic eye disease is a cause of preventable blindness and accurate and timely referral of patients with diabetic macular edema is important to start treatment.
Avinash V. Varadarajan, Pinal Bavishi, Paisan Ruamviboonsuk, Peranut Chotcomwongse, Subhashini Venugopalan, Arunachalam Narayanaswamy, Jorge Cuadros, Kuniyoshi Kanai, George Bresnick, Mongkol Tadarati, Sukhum Silpa-archa, Jirawut Limwattanayingyong, Variya Nganthavee, Joseph R. Ledsam, Pearse A. Keane, Greg S. Corrado, Lily Peng, Dale R. Webster   +17 more
doaj   +1 more source

3D‐Printed Corneal Substitutes: Materials, Fabrication, and Preclinical Progress

Advanced Materials Technologies, EarlyView.
Successful clinical translation of 3D‐printed corneal substitutes relies on the interplay between the bioink properties, cellular component, and the fabrication process. These factors influence the critical properties of the construct, including optical transparency, mechanical stability, suture retention, that ultimately govern long‐term stromal ...
Shadi Moshayedi, Ashley Vazquez, Alexander J. Choi, Dimitrios Karamichos, Jayoung Kim   +4 more
wiley   +1 more source

Histidine Supplementation Stabilizes Hearing and Vision and Improves Growth in HARS1‐Related Autosomal Recessive Disorder Associated With Usher‐Like Symptoms

American Journal of Medical Genetics Part A, EarlyView.
ABSTRACT Autosomal recessive HARS1‐related disorder (originally described as Usher syndrome type 3B) caused by a homozygous Y454S variant in the histidyl‐tRNA synthetase gene (HARS1) is characterized by progressive sensorineural hearing and vision loss and respiratory deterioration with risk for sudden death following febrile illnesses.
Victoria Mok Siu, Rosan Kenana, Rana Chakrabarti, Sarah D. P. Wilhelm, Joseph Andrews, Susan J. Leat, Christina Parker, Michael Miller, Leslie A. Nangle, Wendy McCaul, Ashfia Chowdhury, Natalie Hutchings, Ryan A. Adams, Lauren Guy, Mandy Rhody, Verena Juncal, Marisa I. Mendes, Desiree E. C. Smith, Gajja S. Salomons, Angelica A. Moresco, Daphne L. McCulloch, D. Holmes Morton, Ilka U. Heinemann, C. Anthony Rupar   +23 more
wiley   +1 more source

Ranibizumab in diabetic macular edema

World Journal of Diabetes, 2013
By 2050 the prevalence of diabetes will more than triple globally, dramatically increasing the societal and financial burden of this disease worldwide. As a consequence of this growth, it is anticipated that there will be a concurrent rise in the numbers of patients with diabetic macular edema (DME), already among the most common causes of severe ...
Claudia, Krispel, Murilo, Rodrigues, Xiaoban, Xin, Akrit, Sodhi   +3 more
openaire   +2 more sources

Diabetic Retinopathy and Diabetic Macular Edema [PDF]

, 2015
Diabetic retinopathy and diabetic macular edema result from chronic damage to the neurovascular structures of the retina. The pathophysiology of retinal damage remains uncertain but includes metabolic and neuroinflammatory insults. These mechanisms are addressed by intensive metabolic control of the systemic disease and by the use of ocular anti ...
Steven R, Cohen, Thomas W, Gardner
openaire   +2 more sources